Pain Management

Published by: Global Industry Analysts

Published: Mar. 1, 2008 - 297 Pages

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations

Disclaimers

Data Interpretation & Reporting Level

CAGR Disparities Between Historic & Current Data

Quantitative Techniques & Analytics

Product Definitions and Scope of Study

Pain Management Pharmaceuticals

Pain Management Pharmaceuticals

Pain Management Services

II. EXECUTIVE SUMMARY

1. Industry Overview

Pain Management Market to Witness Steady Growth

Factors Affecting Pain Management Industry

Challenges Faced

Trends and Issues

Generic Drugs Hogs Limelight

Cox II Crisis Tarnishes Industry Growth

Novel Therapies to Propel Opioid and Non- Opioid Therapies

Neuropathic Pain - Still an Underserved Market

Cyclin-dependent kinase 5 (Cdk5)

Drug Dynamics in the Migraine Market

Pain Pathways - Gain a Second Look

Leading Players

Table 1: Leading Players in the Global Pain Management Pharmaceuticals Market (2006): Market Share by Sales for Pfizer, Johnson & Johnson, Novartis, GlaxoSmithkline, and Others (includes corresponding Graph/Chart)

Status of Major Pipeline Drugs for Pain Management: 2007

2. Product Overview

Pain Management: An Overview

Managing Pain

What is Pain?

Assessment of Pain

Pain Management

Pain Management for Neonates

Pain Management in Kids

Pain Management in Older Adult Surgical Patients

Pain Therapeutics - An Introduction

Treatment of Pain

Pharmacologic Method

Non-pharmacological Method

Invasive Procedures

Palliative Care

Alternative Methods

Acupuncture

Biofeedback

Bioelectromagnetic Therapy

Biomagnetism and Magnetotherapy

Guided Imagery

Manual/Massage Therapies

Aromatherapy Massage

Swedish Massage

Deep Tissue Massage

Neuromuscular Therapy

Myofascial Release

Manual Lymph Drainage

Cranial Sacral Therapy

Reflexology

Naturopathy

Relaxation Therapy

Transcendental Meditation

Classification of Pain

Acute Pain

Postoperative pain

Labor pain

Visceral pain

Migraine

Treatment of Migraine

Chronic Pain

Cancer pain

Back Pain

Neuropathic Pain

Arthritic Pain

HIV-Related Pain

Diabetic Neuropathy

Osteo-and Rheumatoid Arthritis Pain

Pain Management Products and Services

Pain Management Pharmaceuticals

Nonprescription Drugs

Acetaminophen

Aspirin

Ibuprofen

Ketoprofen

Naproxen

Pramoxine

Counterirritants

Triethanolamine Salicylate (Trolamine)

Prescription Drugs

General Anesthetics

Local Anesthetics

Non-steroidal Anti-Inflammatories (NSAIDs)

Non-opioid Analgesics

Opioid Analgesics

Pain Management Devices

Electrical Spinal Cord Stimulators

Electrical Stimulus Devices

Transcutaneous Electric Nerve Stimulators (TENS)

Patient-Controlled Analgesia Infusion Devices

Pain Management Services

Home Care/Providence Home Health

Providence Hospices

Pain Management Centers and Clinics

Pain Rehabilitation Programs

3. Regulatory Environment

An Overview of Pain Management Regulation

OTC Painkillers to Carry Conspicuous Safety Warnings

Federal Regulatory Norms of Controlled Substances

DEA Regulations

4. Product Innovations/Introductions

Mallinckrodt Introduces Novel Pain Relieving Agent

Shionogi Unveils Cancer Pain Management Drug

NeuroTherm Launches RF Generators for Treatment of Heel Pain

McNeil Brings Chewable TYLENOL® GoTabs Tablets

Barr Unveils Generic Version of ACTIQ®

Orthofix Unveils e-PainCare

Organon Innovates Org 25969

Orthofix’s BREG Division Launches Polar Care Motorized Cold Therapy System

Zynex Develops New Pain Management Device

Eli Lilly and Company Develops Cymbalta

Pfizer’s Lyrica Gets Nod from the EC

New Pain Management Infusion Pumps from Sorenson

McKinley Unveils Accufuser Pain Management System

5. Recent Industry Activity

Neuromed to Acquire US Rights for Oros Hydromorphone from Alza

China Aoxing to Acquire Chinese Pharmaceutical Company, Shijiazhuang Le Ren

Vyteris Holdings to Acquire Lehigh Valley Technologies

Younger America Pockets Life Without Pain

PainCare Divests Center for Pain Management

Grand Slam Acquires IOMED

Ligand Accomplishes Divesture of AVINZA

CeNeS and Ergomed Collaborate for Phase II Trials of NMDA Antagonist CNS 5161

Sorenson Secures Approval to Market Ambulatory Infusion Pump in China

PainCare Pockets CPMASC

Moog Takes Over Mckinley Medical Corp

PainCare Acquires REC, CareFirst Medical Associates

CLL Pharma Acquires Synt:em

AstraZeneca Partners with Pozen to Bring Novel Pain Management Therapy

Great Outdoors Acquires Somatic Systems Institute

PainCare Partners with Solstice Neurosciences to Offer Pain Management in CD

Elan Confers Eisai with European Rights of Prialt

Evotec Partners with Apeiron Biologics to Bring Novel Pain Therapy

Alpaca Enterprises Acquires Neuroscience Therapy Corp

PainCare Holdings Acquires Desert Pain Medicine Group

Wex Pharma Inks Agreement With Boston Children’s Hospital

Glenmark Inks Agreement with LVT to Market Pain Management Products

EKR Attains North American Marketing Rights for Gelclair

Grand Slam Acquires Cefar Medical

Omeros Acquires Nura

Hospira Inks Agreement with Premier

Pain Therapeutics Enters into Alliance with King Pharmaceuticals

Corgentech Merges with AlgoRx

Elder Pharmaceuticals Ventures into the Indian Pain Management Market

Xanodyne Acquires Pharmaceutical Assets of aaiPharma

Pro-Dex Acquires Dental Technology From IntraVantage

Encore Medical Acquires Compex Technologies

Sosei Acquires Arakis

Corgentech Signs Definitive Merger Agreement With AlgoRx

Elder Pharmaceuticals Enters into Marketing Agreement with TRB Chemedica

University Pain Management Center Signs Agreement with Somnia

Entelos and Organon to Extend Rheumatoid Arthritis (RA) Collaboration

NovaMed Establishes a New Pain Management Center at Indiana

Organon and Uriach Collaborate on Developing Kinase Inhibitors

Toray and Nippon To Co-Develop THCR

AAIPharma Acquires Pain Products

PainCare & Spine & Pain Center in a Definitive Merger Agreement

Elan and Ingenium in a Strategic Alliance

6. Focus on Select Key Players

AstraZeneca PLC (UK)

Eli Lilly and Company (USA)

Glaxo Smithkline Plc (UK)

Johnson & Johnson (USA)

Merck & Co., Inc (USA)

Novartis Pharmaceuticals Corporation (USA)

Pfizer Inc. (USA)

Purdue Pharma (USA)

Sanofi Aventis (France)

Wyeth (USA)

7. Global Market Perspective

Table 2: World Recent Past, Current & Future Analysis for Pain Management by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

Table 3: World* Recent Past, Current & Future Analysis for Pain Management by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 4: World Historic Review for Pain Management by Geographic Region - US, Canada, Japan, Europe, Asia- Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

Table 5: World 20-Year Perspective for Pain Management by Geographic Region - Percentage Breakdown of Dollar Revenue for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart)

Table 6: World Recent Past, Current & Future Analysis for Pain Management Pharmaceuticals by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

Table 7: World* Recent Past, Current & Future Analysis for Pain Management Pharmaceuticals by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 8: World Historic Review for Pain Management Pharmaceuticals by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

Table 9: World 20-Year Perspective for Pain Management Pharmaceuticals by Geographic Region - Percentage Breakdown of Dollar Revenue for US, Canada, Japan, Europe, Asia-Pacific (Excluding Japan), Latin America and Rest of World Markets for Years 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart)

Table 10: World Recent Past, Current & Future Analysis for Pain Management Devices by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

Table 11: World* Recent Past, Current & Future Analysis for Pain Management Devices by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 12: World Historic Review for Pain Management Devices by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

Table 13: World 20-Year Perspective for Pain Management Devices by Geographic Region - Percentage Breakdown of Dollar Revenue for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart)

Table 14: World Recent Past, Current & Future Analysis for Pain Management Services by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

Table 15: World Long-Term Projections for Pain Management Services by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 16: World Historic Review for Pain Management Services by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

Table 17: World 20-Year Perspective for Pain Management Services by Geographic Region - Percentage Breakdown of Dollar Revenue for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart)

III. MARKET

1. The United States

A. Market Analysis

Current & Future Analysis

Pain Statistics in the US

Industry Overview

Measures to Thwart Drug Abuse

Market for Cancer Pain Therapeutics

Leading Players/Brands

Table 18: Leading Oral Pain Relievers in the US Market for Pain Management (2006) - Percentage Breakdown of Value Sales by Brand for Orajel, Anbesol, Baby Orajel, Colgate Peroxyl, Zilactin, Glyoxide, Hyland's, Dentek Temparin, Orajel Mouth Aid, and Others (includes corresponding Graph/Chart)

Table 19: Leading OTC Pain Relievers in the US Market for Pain Management (2006) - Percentage Breakdown of Value Sales by Brand for Advil, Tylenol, Aleve, Bayer, Tylenol PM, Motrin IB, Excedrin, Tylenol Arthritis, Excedrin Migraine, Private label, and Others (includes corresponding Graph/Chart)

Product Launches

Strategic Corporate Developments

Key Players

Eli Lilly and Company

Johnson & Johnson

Merck & Co., Inc

Novartis Pharmaceuticals Corporation

Pfizer, Inc

Purdue Pharma

Wyeth

B. Market Analytics

Table 20: US Recent Past, Current & Future Analysis for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

Table 21: US Long-Term Projections for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 22: US Historic Review for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

Table 23: US 20-Year Perspective for Pain Management by Product Segment - Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 1991, 1997, 2007 & 2010 (Includes corresponding graphs/chart)

2. Canada

Market Analysis

Table 24: Canadian Recent Past, Current & Future Analysis for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

Table 25: Canadian Long-Term Projections for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 26: Canadian Historic Review for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

Table 27: Canadian 20-Year Perspective for Pain Management by Product Segment - Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart)

3. Japan

A. Market Analysis

Current & Future Analysis

Strategic Corporate Developments

B. Market Analytics

Table 28: Japanese Recent Past, Current & Future Analysis for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

Table 29: Japanese Long-Term Projections for Pain Management by Product Segment -Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 30: Japanese Historic Review for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

Table 31: Japanese 20-Year Perspective for Pain Management by Product Segment - Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart)

4. Europe

A. Market Analysis

Current & Future Analysis

Strategic Corporate Developments

B. Market Analytics

Table 32: European Recent Past, Current & Future Analysis for Pain Management by Geographic Region - France, Germany, UK, Italy, Spain, Russia & Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

Table 33: European Long-Term Projections for Pain Management by Geographic Region - France, Germany, UK, Italy, Spain, Russia & Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 34: European Recent Past, Current & Future Analysis for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

Table 35: European Long-Term Projections s for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 36: European Historic Review for Pain Management by Geographic Region - France, Germany, UK, Italy, Spain, Russia & Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

Table 37: European Historic Review for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices And Pain Management Services Markets Independently Analyzed With Annual Revenue Figures in US$ Million For Years 1991 through 2000 (includes corresponding Graph/Chart)

Table 38: European 20-Year Perspective for Pain Management by Geographic Region - Percentage Breakdown of Dollar Revenue for France, Germany, UK, Italy, Spain, Russia & Rest of Europe Markets for Years 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart)

Table 39: European 20-Year Perspective for Pain Management by Product Segment - Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart)

4a. France

A. Market Analysis

Strategic Corporate Developments

Key Player Review

Sanofi Aventis

B. Market Analytics

Table 40: French Recent Past, Current & Future Analysis for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

Table 41: French Long-Term Projections for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 42: French Historic Review for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

Table 43: French 20-Year Perspective for Pain Management by Product Segment - Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart)

4b. Germany

Market Analysis

Table 44: German Recent Past, Current & Future Analysis for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

Table 45: German Long-Term Projections for Pain Management by Product Segment -Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 46: German Historic Review for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

Table 47: German 20-Year Perspective for Pain Management by Product Segment - Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart)

4c. United Kingdom

A. Market Analysis

UK Pain Statistics

Key Player Review

Glaxo Smithkline Plc

AstraZeneca Plc

B. Market Analytics

Table 48: UK Recent Past, Current & Future Analysis for Pain Management by Product Segment -Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

Table 49: UK Long-Term Projections for Pain Management by Product Segment -Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 50: UK Historic Review for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

Table 51: UK 20-Year Perspective for Pain Management by Product Segment - Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart)

4d. Italy

Market Analysis

Table 52: Italian Recent Past, Current & Future Analysis for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

Table 53: Italian Long-Term Projections for Pain Management by Product Segment -Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 54: Italian Historic Review for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

Table 55: Italian 20-Year Perspective for Pain Management by Product Segment - Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart)

4e. Spain

Market Analysis

Table 56: Spanish Recent Past, Current & Future Analysis for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

Table 57: Spanish Long-Term Projections for Pain Management by Product Segment -Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 58: Spanish Historic Review for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

Table 59: Spanish 20-Year Perspective for Pain Management by Product Segment - Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart)

4f. Russia

Market Analysis

Table 60: Russian Recent Past, Current & Future Analysis for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

Table 61: Russian Long-Term Projections for Pain Management by Product Segment -Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 62: Russian Historic Review for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

Table 63: Russian 20-Year Perspective for Pain Management by Product Segment - Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart)

4g. Rest of Europe

A. Market Analysis

Strategic Corporate Development

B. Market Analytics

Table 64: Rest of Europe Recent Past, Current & Future Analysis for Pain Management by Product Segment -Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

Table 65: Rest of Europe Long-Term Projections for Pain Management by Product Segment -Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 66: Rest of Europe Historic Review for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

Table 67: Rest of Europe 20-Year Perspective for Pain Management by Product Segment - Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart)

5. Asia-Pacific

A. Market Analysis

Current & Future Analysis

India

Strategic Corporate Developments

B. Market Analytics

Table 68: Asia-Pacific Recent Past, Current & Future Analysis for Pain Management by Product Segment -Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

Table 69: Asia-Pacific Long-Term Projections for Pain Management by Product Segment -Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 70: Asia-Pacific Historic Review for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

Table 71: Asia-Pacific 20-Year Perspective for Pain Management by Product Segment - Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart)

6. Latin America

Market Analysis

Table 72: Latin America Recent Past, Current & Future Analysis for Pain Management by Product Segment -Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

Table 73: Latin America Long-Term Projections for Pain Management by Product Segment -Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 74: Latin America Historic Review for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

Table 75: Latin America 20-Year Perspective for Pain Management by Product Segment - Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart)

7. Rest of World

Market Analysis

Table 76: Rest of World Recent Past, Current & Future Analysis for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)

Table 77: Rest of World Long-Term Projections s for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 78: Rest of World Historic Review for Pain Management by Product Segment - Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)

Table 79: Rest of World 20-Year Perspective for Pain Management by Product Segment - Percentage Breakdown of Dollar Revenue for Pain Management Pharmaceuticals, Pain Management Devices and Pain Management Services Markets for 1991, 1997, 2007 & 2010 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 131 (including Divisions/Subsidiaries - 142)

Canada 5

Japan 5

Europe 37

France 4

Germany 4

The United Kingdom 12

Italy 6

Rest of Europe 11

Asia-Pacific (Excluding Japan) 7

Latin America 1

Middle East 1

Abstract

This report analyzes the worldwide markets for Pain Management in Millions of US$. The specific product segments analyzed are Pain Management Pharmaceuticals, Pain Management Devices, and Pain Management Services. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual forecasts are provided for each region for the period of 2001 through 2010. A ten-year historic analysis is also provided for these markets with annual market analytics. The report profiles 131 companies including many key and niche players worldwide such as AstraZeneca PLC, Elan Corporation PLC, Eli Lilly and Company, Glaxo Smithkline Plc, Johnson & Johnson, Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Organon International, Inc., Pfizer, Inc., Purdue Pharma, Sanofi Aventis, and Wyeth. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.


Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

Adobe Acrobat Reader 7.0 is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Titles available via "online download" are not affected by this and are still delivered to your reading room immediately.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

Get Full Details About This Report >>

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.